Somnair Sleep is developing a custom-fitted, non-invasive neurostimulation oral appliance designed to treat obstructive sleep apnea.
Somnair has raised $4.3M in total funding. The most recent round was Seed. The last funding was announced in July 2025.
Somnair is headquartered in Baltimore, United States.
Somnair Sleep is developing a custom-fitted, non-invasive neurostimulation oral appliance designed to treat obstructive sleep apnea.
Somnair is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Somnair — Funding & Investors." VCBacked, July 7, 2025, https://www.vcbacked.co/company/somnair. Accessed July 19, 2026.
VCBacked. (2025). Somnair — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/somnair
{{cite web |title=Somnair — Funding & Investors |url=https://www.vcbacked.co/company/somnair |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated